Bioinformatics Research Small Molecule 
Drug Target Review
JUNE 11, 2025
Unimodality does not allow for mixing data: cell data, images, molecular data, clinical data records, small molecule descriptors, ADME Tox data, transcriptomic data, text-based drug and disease representations, clinical trial protocols, publications and patent data, etc.
Drug Target Review
MARCH 28, 2024
Between 2000 and 2020, approximately 30 percent of the newly introduced small molecule drugs were derived from natural products. 1 Researchers have also observed a correlation between greater translatability of natural products and increased progression through clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Nvidia Developer: Drug Discovery
DECEMBER 19, 2023
The applications of artificial intelligence for enzyme generation is an exciting field of research with direct applications in the life sciences. Improved methods for functional annotation are a vital component in enzyme research, enabling the identification and characterization of the functions of newly discovered enzymes.
Drug Target Review
JULY 12, 2023
Many cell lines used in pancreatic cancer research, for example, are generally not genetically aligned with most patients in the clinic. Once a new drug target is identified, a proprietary deep learning artificial intelligence (AI) platform we call Fluency can rapidly identify small molecules that selectively bind to a target of interest.
Dark Matter Blog
AUGUST 31, 2020
The majority of small molecule drugs induce their therapeutic effects by seeking out and binding to their intended target while avoiding most other molecules in the dense milieu of the cell interior. Our overall mission at Arrakis is to expand the set of “druggable” targets for small-molecule medicines to include RNA.
Practical Cheminformatics
JANUARY 8, 2024
Aside from some very brief demos on code generation and literature searches, mentions of LLM applications in preclinical research were scarce. A preprint from Microsoft AI Research provided a broad catalog of potential LLM applications in the physical and life sciences. Most of the drug discovery examples were underwhelming.
Elrig
APRIL 29, 2024
With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Miguel Gancedo Rodrigo Miguel Gancedo Rodrigo Research Investigator, Isomorphic Labs My name is Miguel, and I’m from Murcia, Spain.
Expert insights. Personalized for you.
65 
Let's personalize your content